TFIIIC102 is a pivotal subunit of the general transcription factor IIIC (TFIIIC) complex, essential for the transcriptional assembly and initiation of RNA polymerase III-dependent genes. As a fundamental component in the transcription machinery, TFIIIC102 operates within a highly orchestrated cellular framework to enable the transcription of small nuclear RNAs and other RNA polymerase III substrates, which are crucial for the synthesis of tRNAs and the regulation of various other small RNAs within eukaryotic cells. The expression of TFIIIC102, like many genes, is subject to a complex network of regulatory mechanisms that ensure precise control over its transcriptional levels. This precise regulation is crucial, as it ensures that the diverse array of cellular functions under the governance of RNA polymerase III is conducted in synchrony with the cell's metabolic demands and developmental cues.
Several chemical activators have been proposed to upregulate the expression of TFIIIC102, each acting through distinct pathways and mechanisms. Retinoic acid, for example, may enhance TFIIIC102 expression by interacting with nuclear receptors that function as transcription factors, thus driving the transcription of genes involved in cellular differentiation, which may include TFIIIC102. On a different regulatory level, DNA methylation inhibitors such as 5-Azacytidine could stimulate TFIIIC102 expression by reactivating epigenetically silenced genomic regions, thereby facilitating transcriptional initiation. Histone deacetylase inhibitors, including Trichostatin A and Sodium Butyrate, may promote TFIIIC102 transcription by inducing hyperacetylation of histones, a chromatin modification associated with active transcription. Furthermore, signaling molecules such as Forskolin raise intracellular cAMP levels, which might phosphorylate and activate transcription factors that target the TFIIIC102 gene. Understanding the intricate interplay between these activators and TFIIIC102 expression could provide significant insights into the fundamental processes governing gene regulation and the maintenance of cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate TFIIIC102 by binding to retinoic acid receptors, which can initiate transcriptional activation of genes involved in cell differentiation, potentially including TFIIIC102. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could reactivate epigenetically silenced genes and stimulate the expression of TFIIIC102 by altering its epigenetic state. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can elevate intracellular cAMP, leading to protein kinase A (PKA) activation. PKA may then phosphorylate transcription factors that stimulate TFIIIC102 transcription. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol could upregulate TFIIIC102 by engaging estrogen receptors, which interact with estrogen response elements on DNA, driving the transcription of target genes, including potentially TFIIIC102. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may increase TFIIIC102 expression by inhibiting histone deacetylase, resulting in hyperacetylation of histones near the TFIIIC102 gene, favoring transcriptional activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may stimulate TFIIIC102 transcription by inhibiting GSK-3, which in turn can enhance Wnt signaling, a pathway known to play a role in the control of gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may induce the expression of TFIIIC102 through its inhibitory effect on NF-κB signaling, which could lead to a decrease in pro-inflammatory cytokines and a concomitant increase in certain gene expressions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating sirtuin pathways, resveratrol could stimulate the upregulation of TFIIIC102, potentially through deacetylation of histones or transcription factors that control gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may upregulate TFIIIC102 expression by activating glucocorticoid receptors, which can bind to glucocorticoid response elements upstream of various genes to increase their transcription. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea could induce the upregulation of TFIIIC102 expression as a response to DNA damage or replication stress, through activation of checkpoints that lead to the transcriptional activation of DNA repair genes. | ||||||